Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Synthesis, activity and use reported by Byk Gulden for new tryptase inhibitors

May 4, 2001

Phthalazinones specifically claimed by Byk Gulden for inflammatory airways disorders

May 2, 2001

AxyS receives milestone payment in cathepsin S inhibitor collaboration

May 2, 2001

3-D Pharmaceuticals and Boehringer Ingelheim extend drug discovery collaboration

April 30, 2001

Dual PDE4 and TNF production inhibitors described by Pfizer

April 26, 2001

Cyclic amide-containing HNE inhibitors with good water solubility and in vivo potency

April 26, 2001

Temporary suspension of phase II trials of INS-365 in bronchitis announced

April 25, 2001

Epigenesis and Hybridon join forces to develop antisense drugs for respiratory diseases

April 24, 2001

Singulair approved for treatment of children with asthma as young as two years

April 23, 2001

Vanderbilt researchers patent selective new adenosine A2B antagonists

April 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...